论文部分内容阅读
《中华人民共和国药典》1990年版1部(以下简称药典),由于编制者的努力,在保证人民用药安全,保障人民健康方面发挥着巨大作用。但在使用中也发现一些不足或不妥之处,现就有关问题谈一点粗浅的看法。1 用药禁忌问题1.1 配伍禁忌《药典》对不宜同用的药物的载述不够全面。如甘草(71页)只载述“不宜与甘遂、大戟、芫花同用”,没有海藻;而海藻(261页)述及“不宜与甘草同用”。白蔹(91页)项下有“不宜于乌头类药材同
The 1990 Pharmacopoeia of the People’s Republic of China (hereinafter referred to as pharmacopoeia), due to the efforts of compilers, has played an important role in ensuring the safety of people’s drug use and safeguarding people’s health. However, some inadequacies or inadequacies have also been found in use. We now talk about some superficial views on related issues. 1 Drug Contraindications 1.1 Incompatibility The Pharmacopoeia is not comprehensive enough to describe drugs that are not suitable for use. For example, licorice (page 71) only states that “they should not be used in the same way as garcinia, medlar, and wolfberry” and there is no seaweed. The seaweed (page 261) states that “it is not appropriate to use it together with licorice”. White Pelican (91 pages) has the following: "Not suitable for Aconitum